Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas

Human cytomegalovirus (HCMV) is the leading viral cause of congenital disease and permanent birth defects worldwide. Although the development of an effective vaccine is a public health priority, no vaccines are approved. Among the major antigenic targets are glycoproteins in the virion envelope, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabata, Takako, Petitt, Matthew, Li, Julia, Chi, Xiaoyuan, Chen, Wei, Yurgelonis, Irina, Wellnitz, Sabine, Bredl, Simon, Vicente, Tiago, Yang, Xinzhen, Dormitzer, Philip R., Pereira, Lenore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315547/
https://www.ncbi.nlm.nih.gov/pubmed/35891239
http://dx.doi.org/10.3390/vaccines10071074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315547/
https://www.ncbi.nlm.nih.gov/pubmed/35891239
http://dx.doi.org/10.3390/vaccines10071074

Ejemplares similares